Traction reaction during cesarean section
Conditions
Interventions
Group T1:Tigecycline Fumarate Injection, 0.015 mg/kg, administered by intravenous infusion over 10 minutes.
Group T2:Tigecycline Fumarate Injection, 0.02 mg/kg, administered by intravenous infusion over 10 minutes.
Group T3:Tigecycline Fumarate Injection, 0.025 mg/kg, administered by intravenous infusion over 10 minutes.
Group C:20 mL of normal saline, administered by intravenous infusion over 10 minutes.
Sponsors
Guanyun people's Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. ASA classification I/II 2. Age 20–45 years 3. BMI 18.8–30.0 kg/m^2 4. Gestation 37–42 weeks
Exclusion criteria
Exclusion criteria: 1. Contraindications to neuraxial anesthesia 2. Accompanied by gestational hypertension 3. Hepatic or renal insufficiency 4. Accompanied by severe cardiopulmonary disease 5. Placenta previa 6. Intrauterine fetal distress 7. Allergy or intolerance to any study drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative traction reaction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative shivering;Ramsay score;Satisfaction score after surgery;Occurrence of adverse reactionsrelated to tegileridine;Hemodynamic indices at special moments in the perioperative period; | — |
Countries
China
Contacts
Public ContactQian Long
Guanyun people's Hospital
Outcome results
None listed